Eighteen models were evaluated, and the risk factors for complications and poor glycemic control were identified, with the most important risk factors being the duration of T2D, the duration of unadjusted hypoglycemic treatment, types of insulin, number of hypoglycemic drugs, and total cost of hypoglycemic therapy. Here, INS is linked to type 2 diabetes mellitus.